Charvi Arora
For decades, counternarcotics efforts largely followed familiar patterns. Authorities tracked crops, monitored trafficking corridors, intercepted shipments, and targeted cartels moving drugs across borders. Fentanyl has changed that model.
Unlike plant-based narcotics such as heroin or cocaine, fentanyl is a synthetic drug that relies heavily on dual‑use chemical precursors that also serve legitimate pharmaceutical and industrial markets. This shift has fueled a national crisis; synthetic opioids, primarily fentanyl, account for 60 percent of all overdose deaths in the United States, claiming approximately 48,000 lives annually. Tiny quantities can be extraordinarily lethal; just two milligrams can constitute a deadly dose, according to a U.S. Customs and Border Protection (CBP) official at U.S. Embassy New Delhi.
The invisible supply chain
“We are confronting a commodity that can be manufactured almost anywhere, in highly concentrated forms, and moved through the same global trade, financial, and communications systems that support legitimate commerce,” says a Homeland Security Investigations (HSI) official at U.S. Embassy New Delhi. HSI is the principal investigative arm of the U.S. Department of Homeland Security.
This has significantly increased the volume of actionable information, investigative leads, and potential targets, necessitating the integration of border, financial, cyber, and international tools into a coordinated approach.
That reality has reshaped how U.S. law enforcement approaches the fentanyl threat. Agencies now increasingly focus on identifying precursor supply chains, mapping financial and logistics networks, analyzing digital communications, and disrupting trafficking systems before the drug reaches U.S. communities.
“Our work is far less about isolated seizures and far more about systematically identifying and dismantling the organizations and enablers behind them,” the HSI official says.
This systemic approach is supported by “Detect and Defeat” legislative proposals aimed at expanding authorities’ ability to collect and share data across the supply chain.
Hiding in global commerce
Primary trafficking routes for fentanyl include ports of entry, international mail and express consignments, and maritime borders. “Concealment methods are diverse, ranging from individuals and hidden compartments in vehicles to being disguised within legitimate cargo or mislabeled small parcels,” says the CBP official.
CBP employs comprehensive strategies and advanced tools to identify high-risk shipments. The agency utilizes a sophisticated, multi-faceted system that integrates intelligence gathering, advanced analytical capabilities, and specialized inspection technologies. This approach is continually being enhanced with cutting-edge technologies, including artificial intelligence (AI) and machine learning, to identify complex indicators and inspection results that may not be apparent through conventional screening methods. Furthermore, CBP is refining its data collection processes for various shipment types to improve the identification of potentially suspicious packages within intricate logistics networks.
The challenge, officials say, stems from the nature of fentanyl production itself. Instead of visible poppy or coca fields, producers source chemicals through global supply chains, often ordering them online and shipping them in small, misdeclared consignments that blend into normal commerce. “Its dual‑use nature makes it difficult for authorities to distinguish lawful trade from illicit supply and to regulate specific substances without disrupting legitimate businesses,” the HSI official explains. “Traffickers can quickly switch to alternative or ‘pre‑precursor’ chemicals when controls tighten.”
Targeting the network
In response to this evolving model, U.S. agencies have reworked where and how they intervene. Rather than focusing on intercepting finished drugs at the border, agencies increasingly target the broader systems that enable fentanyl production and movement.
“Transnational criminal organizations are most vulnerable at the points where they must intersect with legitimate systems—global trade, finance, travel, communications, and the physical movement of goods and people,” says the HSI official. The agency continuously assesses these intersections to identify emerging vulnerabilities and apply pressure using investigative authorities, advanced analytics, and domestic and international partnerships.
CBP, meanwhile, leverages intelligence, data analysis, and rapid screening to identify high-risk cargo and passengers earlier in the supply chain. “It employs innovative strategies like Forward Operating Laboratories, which provide rapid, on-site precursor screening and fentanyl testing, significantly reducing identification time from weeks to minutes,” says the CBP official. This enables faster law enforcement action, intelligence collection, and prosecution.
Pre-border enforcement has also become central to CBP’s strategy. It works with foreign governments, private industry partners, and forward-deployed personnel to interdict precursor chemicals and manufacturing equipment before they reach illicit networks. In addition, CBP’s Office of Trade analyzes supply chain vulnerabilities to target shipments of precursors and equipment entering through legitimate trade pathways.
HSI approaches fentanyl precursors “as a global illicit supply chain challenge, not just a narcotics issue,” the official says. To identify high-risk activity, HSI analyzes trade data, shipping manifests, customs declarations, and commercial records for anomalies such as unusual routing patterns, inconsistent product descriptions, or repeated low-volume shipments that do not align with a company’s stated business. Financial investigations run in parallel, tracing payments through banks, shell companies, money service businesses, and trade-based schemes to identify networks supporting precursor procurement.
Officials say partnerships with legitimate industry are also increasingly important. HSI works with chemical producers, distributors, and logistics firms to improve visibility into suspicious orders and encourage reporting of questionable transactions or customers.
The U.S.-India cooperation framework
Because fentanyl production relies heavily on globally traded chemicals, international cooperation is key. India plays an important role as a major producer and exporter of pharmaceutical and industrial chemicals.
“India is a critical counterpart on synthetic drugs and precursor chemicals,” the HSI official says. “Our engagement is framed as a shared supply-chain challenge: working together to prevent the diversion of legitimate chemicals and expertise into illicit fentanyl and other synthetic drug production.”
Cooperation increasingly focuses on strengthening regulatory frameworks, supported by initiatives like technical exchanges and training on financial and trade-based investigations, as well as cyber- and dark web-enabled trafficking. “A central pillar of this cooperation is our engagement under the U.S.-India Drug Policy Framework, which provides a structured platform for aligning priorities, sharing insights on emerging trends, and coordinating policy and operational responses,” the HSI official adds.
CBP also works with Indian authorities under mechanisms like the Customs Mutual Assistance Agreement . “This collaboration involves sharing intelligence to disrupt online sales and developing training and advisory resources to build capacity for targeting and disrupting synthetic drug movements,” the CBP official says.
To deepen cooperation, HSI has proposed bilateral initiatives such as Trade Transparency Units and Transnational Criminal Investigative Units aimed at improving real-time information sharing and joint targeting of illicit supply chains.
“Only through close partnership, mutual trust, and continuous information sharing can we effectively confront the complex challenges associated with synthetic drugs and precursor chemicals,” the HSI official adds.
The interagency engine
The fentanyl response depends heavily on coordination between agencies operating at different points in the enforcement chain. CBP focuses on identifying and interdicting illicit shipments at ports of entry and across trade routes, while HSI uses seizure data, financial records, intelligence analysis, and investigative leads to identify and dismantle the criminal networks behind them.
Officials say information gathered through CBP interdictions often feeds directly into HSI investigations. “Continuous information sharing occurs between CBP and HSI, with HSI units at CBP’s National Targeting Center analyzing shipping and seizure data to identify fentanyl trafficking organizations,” the CBP official says. The agencies also share real-time intelligence on trafficking routes, smuggling methods, suspicious shipments, and emerging trends, while collaborating through joint task forces and targeting centers.
CBP’s rapid testing technologies and cargo-screening systems support intelligence collection and prosecution efforts, while HSI investigators use those leads to map trafficking organizations, track precursor supply chains, and coordinate follow-up investigations with federal, state, local, and international partners.
The path forward
Ultimately, the fight against fentanyl reflects “whole-of-government” recognition that in the age of synthetics, seizures alone are no longer enough. By treating fentanyl as a global supply-chain and public health crisis rather than a traditional smuggling problem, authorities are moving toward a model of continuous disruption. As trafficking networks increasingly hide within global commerce, the race to adapt—through AI, diplomacy, and forensic finance—remains the front line of modern drug enforcement.
(This article was first published in the U.S. Embassy’s SPAN magazine)
